INTRODUCTION
============

Protein synthesis requires quality control systems to ensure accuracy between the genetic information carried by messenger RNAs (mRNAs) and the sequence of the corresponding proteins. In bacteria, when translation proceeds on a truncated mRNA, ribosomes carry on the elongation process until the mRNA 3′-end is reached. There, translation termination is inefficient and ribosomes stall with the nascent polypeptide chain on the peptidyl-tRNA site (P-site), whereas the aminoacyl-tRNA site (A-site) is empty or only partially filled with the incomplete mRNA ([Figure 1](#F1){ref-type="fig"}A). A quality-control mechanism, referred as *trans*-translation, rescues and recycles the stalled ribosomes and targets the incomplete protein for degradation. This process requires a specific RNA acting as both a transfer and a messenger RNA (tmRNA, ssrA or 10Sa RNA). TmRNA has a tRNA (TLD) and a mRNA (MLD)-like domains. The TLD is aminoacylated with alanine (Ala) by alanyl-tRNA synthetase (AlaRS) and the MLD is a short (27--105 nt-long) internal open reading frame (ORF). During *trans*-translation, alanyl-tmRNA enters the A-site and, despite the lack of codon--anticodon interaction, the incomplete peptide chain is transferred to its alanine. Translation then switches to the MLD, which encodes a tag that targets the incomplete protein to degradation. During *trans*-translation, tmRNA acts in concert with specific ligands \[for a recent review, see ([@B1])\] including 70S ribosomes, AlaRS ([@B2]), small protein B (SmpB) ([@B3]), elongation factor Tu (EF-Tu) ([@B4]) and ribosomal protein S1 ([@B5]). Figure 1.Ribosomal protein S1 is dispensable for the tRNA-like function of tmRNA. (**A)** Schematic representation of the first step of *trans*-translation (*trans*-peptidation) on polyU mRNAs. The light gray ovals are the ribosomal subunits (the larger for the 50S and the smaller for the 30S). The white ovals are, from right to left, the decoding site (A); the transpeptidyl-site (P) and the exit site (E). tRNAs and tmRNA are depicted as hooks and as a lasso, respectively (for further insights see (1)). (**B)** Western blots showing the quasi-absence of S1 in purified 'S1-free' 70S ribosomes compared to genuine 70S ribosomes. (**C)** The *trans*-translation *in vitro* assay is inactive in the absence of SmpB. (**D)** Assay of alanine *trans*-peptidation (asterisk in **A**), using S1-free 70S ribosomes and increasing amounts of exogenous S1. *Trans*-peptidation is monitored by the incorporation of ^3^H-Ala from alanyl-tmRNA into polyPhe and is normalized to the level of translation, measured in parallel by the incorporation of ^14^C-Phe (section 'Experimental procedures'). The *Y*-axis represents the quantities (number of pmoles) of ^3^H alanine incorporated per assay.

S1, the largest ribosomal protein, binds weakly and reversibly to the head of the 30S ribosomal subunit ([@B6]), with an apparent binding constant of 20 nM \[([@B7]), and M. Hallier, unpublished Surface Plasmon Resonance data\]. S1 consists of six imperfectly repeated motifs, each organized in an oligonucleotide/oligosaccharide binding (OB) fold ([@B8]). Whereas the first two N-terminal motifs are required for anchoring S1 to the head of the ribosomal small subunit, the four C-terminal motifs face the solvent side ([@B9]).

Protein S1 co-purifies *in vivo* with an over-expressed tmRNA--SmpB complex ([@B10]) and the protein binds tmRNA *in vitro* with a 10--100 nM apparent binding constant ([@B5],[@B11; @B12; @B13]). Its exact role during *trans*-translation is unclear. Conceivably, S1 could prevent degradation of the tmRNA in the cytoplasm before it is loaded onto the ribosome and/or it could be involved in translation resumption onto tmRNA internal ORF, especially since the latter lacks a Shine Dalgarno element (SD) or an initiation codon (in most species, translation resumes onto an alanine codon). However, S1 stands at the junction of the head, platform and main body of the 30S subunit, at the opposite side of the decoding site ([@B14]). This location makes a concomitant binding of S1 to the stalled ribosome and to tmRNA during initial loading very unlikely. Moreover, recent cryo-EM data indicate that tmRNA enters stalled ribosomes in the absence of S1 ([@B15],[@B16]), arguing for a role of S1 in *trans*-translation in solution and not when bound to the ribosomes.

Protein S1 is essential for cell viability ([@B17]) and autoregulates its own synthesis ([@B18]), so that its concentration cannot be easily manipulated *in vivo* (see subsequently). We therefore developed an *in vitro* method to assess precisely its role in *trans*-translation. Assays were set up with purified recombinant proteins ([@B19]) and ribosomes depleted from protein S1 ([@B20]). We took advantage of the fact that polyU genuinely lacks a termination codon, so that its translation in the presence of Phe-tRNA^Phe^ yields stalled ribosomes, wherever translation initiates on the polyU RNAs. We found that S1 is dispensable for the codon-independent transfer of the stalled nascent peptide chain to the alanine from alanylated-tmRNA^Ala^ but is required for the translation of tmRNA internal ORF. The N-terminal domain of the protein that is required for ribosome binding is dispensable for *trans*-translation, indicating that the role of S1 during tmRNA-mediated protein tagging takes place outside from the ribosome, presumably when in complex with soluble tmRNA. Also, tmRNA-mediated protein tagging is reduced *in vivo* when the expression levels of protein S1 are either reduced or increased, compared to wild-type cells. Altogether, these results indicate that S1 plays an important role during *trans*-translation that is distinct from its documented role during protein synthesis.

RESULTS AND DISCUSSION
======================

Protein S1 is dispensable for codon-independent *trans*-peptidation but required for the mRNA function of tmRNA
---------------------------------------------------------------------------------------------------------------

Mechanistically, *trans*-translation proceeds in two steps: (i) codon-independent transfer of the stalled polypeptide to the alanyl-tmRNA via peptide bond formation (tRNA role of tmRNA), and then (ii) ORF switching from the original mRNA to tmRNA (mRNA role of tmRNA). These two steps were dissociated *in vitro* to monitor the influence of the S1 protein on each of them. To monitor the role(s) of protein S1, we started from purified S1-free 70S ribosomes ([Figure 1](#F1){ref-type="fig"}B), and added back variable amounts of pure recombinant S1 to the reaction mixture. To assay the tRNA role of tmRNA, we monitored the incorporation of labeled alanine from Ala-tmRNA to polyPhe in the absence of Ala-tRNA. Translation then cannot resume on the tmRNA ORF and the assay measures only codon-independent *trans*-peptidation. To confirm that the signal is only due to *trans*-translation, a control experiment was carried out in the absence of SmpB, a protein indispensable to the process. No signal is detected in the absence of SmpB ([Figure 1](#F1){ref-type="fig"}C). As shown in [Figure 1](#F1){ref-type="fig"}D, *trans*-peptidation takes place in the absence of S1 protein, and is slightly stimulated by it (by ∼25% from 0.3 to 1.2 μM of S1 versus 0.3 μM of S1 free-ribosomes or tmRNA), leading to the incorporation from ∼3 to 4 pmoles of ^3^H alanine.To monitor specifically the effect of S1 on translation of the tmRNA ORF, we added all purified tRNAs and aminoacyl-tRNA synthetases and recorded the incorporation of glutamic acid, the fourth amino acid of this ORF ([Figure 2](#F2){ref-type="fig"}A). This incorporation was undetectable in the absence of S1, and passed through a maximum of ∼3 to 4 pmoles, for a same concentration of S1 versus the ribosomes. Therefore, S1 is essential for the glutamic acid incorporation within the tag-reading frame but becomes detrimental when present in excess ([Figure 2](#F2){ref-type="fig"}B). Increasing the concentration of S1 leads to the binding of more than one protein per tmRNA ([@B11],[@B12]), which might be detrimental for the translational activity (MLD function) of tmRNA. Figure 2.Ribosomal protein S1 is essential for the mRNA function of tmRNA. (**A)** *Trans*-translation of polyU RNA; the position of Glutamic acid, the fourth amino acid of the tmRNA tag, is emphasized by an asterisk. (**B)** Incorporation of ^14^C Glu during *trans*-translation in the presence of S1-free ribosomes and increasing amounts of exogenous S1 is normalized to the level of translation. The *Y*-axis represents the quantities of pmoles of ^14^C glutamic acid incorporated per assay. (**C)** Incorporation of ^14^C Glu during *trans*-translation in the presence of S1-free ribosomes and increasing amounts of exogenous S1~R1--R4~ is normalized to the level of translation. The *Y*-axis represents the quantities (number of pmoles) of ^14^C glutamic acid incorporated per assay.

A mutant S1 protein inactive in ribosome binding enhances *trans*-translation *in vitro*
----------------------------------------------------------------------------------------

Of the six contiguous S1 motifs, the two N-terminal ones are required for ribosome binding and the next three (R1--R3) for mRNA binding ([@B6]). To determine whether S1 participates to *trans*-translation via its association to the stalled ribosome, we used a N-terminal truncated S1 variant that only retains motifs R1--R4 (S1~R1--R4~). This variant fails to bind ribosomes *in vivo* whereas it binds tmRNA ([@B12],[@B13]). S1~R1--R4~ stimulates glutamic acid incorporation *in vitro* as the intact protein ([Figure 2](#F2){ref-type="fig"}C), indicating that this stimulation involves binding to tmRNA independently of the ribosome. The maximal stimulation persists at higher amounts of S1~R1--R4~ compared with S1 (compare [Figure 2](#F2){ref-type="fig"}B and C), probably reflecting the weaker affinity of S1~R1--R4~ for tmRNA ([@B12]).

Overall effect of protein S1 on *trans*-translation
---------------------------------------------------

To record the overall effect of S1 upon *trans*-translation, we again recorded the incorporation of labeled Ala, but in the presence of all factors required for the translation of the tmRNA ORF. In that case the incorporation of Ala reflects both *trans*-peptidation and translation of the four Ala codons of the ORF (**A**NDENY**A**L**AA**) ([Figure 3](#F3){ref-type="fig"}A). Ala incorporation is slightly detected in the absence of S1, presumably reflecting the sole *trans*-peptidation step ([Figures 1](#F1){ref-type="fig"}D and [3](#F3){ref-type="fig"}B). At similar concentrations of S1 and S1 free-ribosomes, Ala incorporation is maximal ([Figure 3](#F3){ref-type="fig"}B), as observed for Glu ([Figure 2](#F2){ref-type="fig"}B). This incorporation of ∼15 pmoles is consistent with the ∼3 pmoles of alanine or glutamic acid obtained at the same concentration of S1 ([Figures 1](#F1){ref-type="fig"}D and [2](#F2){ref-type="fig"}B, respectively) and accounts for the incorporation of five alanines, one carried by the TLD and the other four from the tag. Overall *trans*-translation leads to the incorporation of five Ala, to be compared to the single one (carried by tmRNA) incorporated during *trans*-peptidation or the single Glu incorporated during *trans*-translation. Increasing further the concentration of S1 decreases Ala incorporation, but not as drastically as for Glu ([Figure 2](#F2){ref-type="fig"}B). The higher rate of Ala incorporated at the highest concentration (1.2 μM) of S1 probably reflects the sum of the incorporation of the first alanine (transpeptidation, [Figure 1](#F1){ref-type="fig"}D) plus the translation of the first alanine codon from tmRNA internal ORF. Figure 3.Overall effect of S1 and S1~R1--R4~ on protein tagging. (**A)** Same as [Figure 2](#F2){ref-type="fig"}A, except that Ala residues are shown in bold. (**B)** Incorporation of ^14^C Ala from alanyl-tmRNA and alanyl-tRNA^Ala^ during *trans*-translation in the presence of S1-free ribosomes and increasing amounts of exogenous S1 is normalized to the level of translation. The *Y*-axis represents the number of pmoles of ^14^C alanine incorporated per assay. (**C)** Similar as in [Figure 3](#F3){ref-type="fig"}B, except that a truncated S1 protein (S1~R1--R4~) lacking the first 193 N-terminal aminoacids and therefore unable to bind ribosomes, was used ([@B12]). The *Y*-axis represents the quantities of ^3^H Alanine incorporated per assay.

Mutant S1~R1--R4~ also stimulates alanine incorporation *in vitro* as the intact S1 protein does ([Figure 3](#F3){ref-type="fig"}C). As previously observed for glutamic acid incorporation, maximal stimulation requires higher amounts of S1~R1--R4~ compared with wild type S1. Altogether, these results indicate that the role of protein S1 during *trans*-translation is distinct from its documented role during protein synthesis. Gram-positive bacteria lack ribosomal protein S1, whereas *trans*-translation is detected in *Bacillus subtilis*. In *B. subtilis*, the *ypf*D gene expresses a protein containing four repeated RNA-binding motifs ([@B21]), each corresponding to four of the six repeated motifs present in S1 from *Escherichia coli*. The *B. subtilis* S1 mimic has sequence similarity to the four C-terminal domains of S1 from *E.coli*, corresponding to mutant S1~R1--R4~. As shown in this report, mutant S1~R1--R4~ can sustain *trans*-translation *in vitro*. Therefore, the *ypf*D gene may be required for translation of tmRNA internal ORF during *B. subtilis trans*-translation.

*In vivo* modulation of ribosomal protein S1 concentration affects *trans*-translation
--------------------------------------------------------------------------------------

The *in vitro* results indicate that the amount of ribosomal protein S1 added in the assays can modulate *trans*-translation. To evaluate the effect of varied concentrations of ribosomal protein S1 on *trans*-translation *in vivo*, we used a modified chromosomal *ssrA* allele (*ssrAH7*) encoding a histidine stretch within the tmRNA ORF that replaces the terminal aminoacids, which normally constitutes an essential recognition signal for the proteases ([@B22]). Resulting his-tagged *trans*-translated proteins are not degraded and can be isolated on Ni^2+^ columns and quantified relatively to the amount of total proteins extracted from strains expressing various levels of S1 (see subsequently). In order to avoid the influence of S1 decrease or increase on protein synthesis, the same amounts of total proteins were applied to each of the columns for all the strains used. *Trans*-translated proteins were separated from bulk proteins onto an imidazole gradient on a Ni-NTA column and immunoblots using anti-His antibodies were performed on each collected fraction (Supplementary Data). The negative control prepared from a strain that does not express tmRNA-His7 (and contains an endogenous level of S1) did not display any significant signal (data not shown). On the other hand, equivalent elution profiles were obtained for the strains expressing tmRNA-His7 and various levels of S1 (Supplementary Data). In each case, fractions 3 were found to contain most of the tagged proteins. These fractions were pooled and applied to a desalting column to remove excess of imidazole. Afterwards, protein amounts were measured by UV absorbance at 280 nm (section 'Experimental procedures').

Since ribosomal protein S1 is indispensable for cell survival, it was not possible to reproduce *in vivo* the zero S1 condition obtained *in vitro*. Various alterations in the gene coding for S1 have been assayed *in vivo*, showing that both the NH~2~-terminal domain and R3 are essential for function ([@B23]). Nevertheless, we first varied the concentration of S1 by constructing a strain from which the essential ribosomal protein can be depleted using the same approach as previously described ([@B24]). For this purpose, the chromosomal *rpsA* gene (encoding S1) was deleted from the *ssrAH7* strain that carries the pJFR32 plasmid where *rpsA* is controlled by the IPTG inducible *lac* promoter (section 'Experimental procedures') ([@B24]). As expected, removal of the inducer strongly increased the doubling time of the *ssrAH7 rpsA::kanR* strain ([Figure 4](#F4){ref-type="fig"}A, lane 4). After 4 h of depletion, the ribosomal protein S1 was found to be 3-fold less abundant than in the wild-type *ssrAH7 rpsA* strain as judged by Western blot analyses ([Figure 4](#F4){ref-type="fig"}A; compare lanes 1 and 4). Importantly, the deleted but complemented strain *ssrAH7 rpsA::kanR* (+IPTG) also displayed less amount of S1 (1.8-fold) indicating that expression of the *rpsA* gene from the pJFR32 plasmid ([@B24]) is not sufficient to restore a wild-type level of S1 as well as a wild-type doubling time ([Figure 4](#F4){ref-type="fig"}A; compare lanes 3--1). Figure 4.Quantification of the *trans*-translated proteins in cells expressing varied S1 concentration. (**A)** Strains depleted for S1 contain less his-tagged proteins. Lanes 1 and 2: control strain *ssrAH7 rpsA* grown in the absence (−) or presence (+) of IPTG, respectively. Lanes 3 and 4: *rpsA* deleted strain (*ssrAH7 rpsA::kanR*) grown in the presence (+; complementation condition) or absence of IPTG (−; depletion condition), respectively. IPTG induces expression of the extra plasmid-borne *rpsA* copy present in the strains (section 'Experimental procedures'). Western blot analysis was performed for samples of the cultures used to purify his-tagged protein. Blot was revealed with S1 antibodies mixed with PNPase antibodies to normalize quantification. The S1/PNPase ratio was determined by quantification of the S1 and PNPase signals on a chemi-smart 5000 (Vilbert-Lourmat). Doubling time of each strain is indicated. Amounts of purified his-tagged protein were measured by absorbance (section 'Experimental procedures'). Percentage of his-tagged proteins was determined after normalization to the amount of total proteins extracted from each strain and strain *ssrAH7 rpsA* (lane 1) was used as reference. (**B)** Excess of free S1 affects the accumulation of *trans*-translated proteins. Up: schematic representation of the *rpsA-lacZ* chromosomal fusion used as translational reporter. Western blot analysis was performed as described earlier. β-Galactosidase activities from *rpsA-lacZ* translational fusion are given in β-galactosidase units corresponding to nanomoles of ONPG hydrolyzed per min and per mg of total protein. The values shown are averages of three independent assays. Presence of the pS1 plasmid strongly decreases β-galactosidase synthesis (20-fold) due to S1 autogenous control. Doubling time is given for both strains. Percentage of his-tagged protein was determined as in **B**, and strain *ssrAH7 rpsA, rpsA-lacZ* containing the control plasmid pAC, was used as reference.

In these conditions of lower abundance of ribosomal protein S1, we observed a ∼2-fold decrease of *trans*-translation as judged by quantification of the *in vivo* his-tagged proteins that were purified from the corresponding strains ([Figure 4](#F4){ref-type="fig"}A, lanes 3 and 4 compared to lane 1). Moreover, the lower level of *trans*-translation (46.5%) was obtained for the strain containing the lower detectable amount of ribosomal protein S1 ([Figure 4](#F4){ref-type="fig"}A, lane 4). To exclude that the lower levels of his-tagged proteins result from the influence of S1 on protein synthesis and consequently on *trans*-translation, all the measures were performed at identical growth rates for each strain.

It is known that excess of S1 can repress its own translation ([@B18]). In other words, the *rpsA* gene is autoregulated and consequently a S1 overexpression is hardly achievable *in vivo*. This is exemplified in the first attempt we made where the *ssrAH7 rpsA* strain containing the pJFR32 plasmid was grown in the presence of IPTG to induce expression of the extra plasmid-borne *rpsA* copy ([Figure 4](#F4){ref-type="fig"}A, lane 2). Indeed, this condition did not allow overexpression of S1 and, on the contrary, we observed a slight decrease of the S1 signal ([Figure 4](#F4){ref-type="fig"}A, compare lanes 1 and 2).

In a second attempt to increase endogenous expression of the S1 protein we exploited the fact that the presence of an excess of free S1 in the cell can be followed using a chromosomal fusion between the *rpsA* translation initiation region (TIR) and the *lacZ* gene as a translational reporter system ([@B25]; [Figure 4](#F4){ref-type="fig"}B). This *rpsA-lacZ* chromosomal fusion leads to a β-galactosidase synthesis that is driven at the transcription level by the *lac* promoter, and most importantly, at the translational level by the *rpsA* TIR. As a result, when excess of free S1 is present in the cell, the β-galactosidase activity is decreased due to S1 autogenous control ([@B25]). The *rpsA-lacZ* fusion was thus introduced in the *ssrAH7 rpsA* strain (section 'Experimental procedures') and the resulting strain (*ssrAH7 rpsA*, *rpsA-lacZ*) was transformed by the control plasmid pACYC184 (pAC) or its pS1 derivative that expresses S1 under the control of its own promoter ([@B26]). β-Galactosidase activity was measured for both strains. As expected, presence of the pS1 plasmid strongly decreases β-galactosidase activity indicating that the pS1 containing strain does harbor an excess of free S1 protein, as also independently demonstrated by western blot analyses ([Figure 4](#F4){ref-type="fig"}B). The cells doubling-time is not influenced by the overexpression of S1 (50 min versus 55 min, [Figure 4](#F4){ref-type="fig"}B). His-tagged proteins were isolated from the same strains except that in this case the *rpsA-lacZ* expression was not IPTG induced to avoid S1 titration by the *rpsA-lacZ* transcripts. A decrease of the *trans*-translated proteins (from 100 to 85%) was observed in the pS1-containing strain ([Figure 4](#F4){ref-type="fig"}B) that reflects *trans*-translation inhibition by excessive amounts of S1, as observed *in vitro* ([Figures 2](#F2){ref-type="fig"}B and [3](#F3){ref-type="fig"}B), probably by preventing efficient decoding of the tag-reading frame. These results suggest that the concentration of S1 *in vivo* is optimally set up for efficient *trans*-translation and that minor up- or down- regulations of S1 are deleterious for ribosome rescue. However, *in vitro*, the highest inhibitory effect was obtained with a 200% excess of S1 ([Figure 3](#F3){ref-type="fig"}B). A same extent of *trans*-translation inhibition was impossible to reach *in vivo*, since excess amounts of S1 could hardly exceed 130% ([Figure 4](#F4){ref-type="fig"}B, compare the two lanes). In accordance with the present study, the use of an inducible plasmid overexpressing the S1 protein, or protein fragments, leads to a same extent of variation of the *in vivo* tagging activity of tmRNA, from 25 to 35% ([@B12]). Altogether, these data suggest that the S1 protein, by playing its role outside the ribosome, may bind tmRNA early during *trans*-translation ([@B5],[@B11]).

EXPERIMENTAL PROCEDURES
=======================

Chemicals and enzymes
---------------------

All the common reagents and enzymes were purchased from Sigma, except for tRNAs, Creatin phosphate and Creatine kinase, obtained from Roche (Meylan, France), Trichloroacetic acid (TCA) from Acros Organics (Noisy le Grand, France), Urea from Eurobio (Les Ulis, France) and radiolabeled amino acids from Perkin-Elmer (Courtabœuf, France).

Purification of the 'PURE System' factors
-----------------------------------------

The translation factors necessary to the cell free *in vitro* protein synthesis were purified according to Shimizu and co-workers ([@B19]). Briefly, His-tagged proteins were overexpressed in *E.coli* cells transformed with their respective plasmids. After lysis the extracts were centrifuged and the supernatants applied on Ni^2+^-Sepharose chelating columns (HisTrap HP, Amersham) by using the AKTA Basic system (Amersham). After elution by a 10--300 mM linear gradient of imidazole, the fractions containing the proteins were pooled and concentrated on centrifugal filter devices (Amicon® Ultra-15, Millipore) before being dialyzed against a stock buffer containing 30% of glycerol. All the proteins were frozen in small aliquots at −80°C.

Cloning, expression and purification of *trans*-translation specific components
-------------------------------------------------------------------------------

*Escherichia coli* tmRNA was overproduced *in vivo* in strain JM109(DE3) transformed with a derivative of plasmid pGEMEX-2 carrying the *ssrA* gene under the control of the T7 RNA polymerase promoter. Purification was performed according to Ushida *et al*. ([@B27]). SmpB was purified from the *E.coli* strain BL21(DE3)/pet-21a-SmpB, as described before ([@B28]). His-tagged ribosomal protein S1 was purified under denaturing conditions ([@B5]) and slowly refolded directly on the HisTrap column by using a linear gradient of Urea, from 6 to 0 M (60 ml for 10 h). The protein was then eluted and dialyzed against the stock buffer as described earlier.

*In vitro trans*-translation assays
-----------------------------------

The translation assays were prepared essentially using the method described by Shimizu *et al*. ([@B19]). Slight modifications were nevertheless introduced to the method in order to detect optimal yields of *trans*-translated proteins. Prior to triggering *trans*-translation, polyUridines RNAs were first translated for 30 min in standard conditions. Some free S1 is likely to bind the polyU RNAs. However, S1 binds the 30S subunits or tmRNA one order of magnitude tighter than to polyU RNAs ([@B6]). SmpB, tmRNA and various amounts of S1 were then added in that order for 30 additional minutes in a final volume of 50 μl. The *trans*-translation factor mix was the same as previously described ([@B29]) except that it contains 0.3 μM ribosomes, 0.3 μM tmRNA, 0.6 μM SmpB and 1.2 μM elongation factor EF-Tu. The bulk of tRNAs (Roche) was adjusted to 4 μM and release factors (RFs) were removed in order to standardize the results. No putrescin was used during the reaction. Different radiolabeled amino acids were incorporated to the reaction mixture in order to monitor the various steps of the reaction: (i) ^14^C phenylalanine (18.5 kBq corresponding to 1 nmol) was used for measuring the rate of translation of the polyU RNA (ii) ^14^C alanine (9.25 kBq corresponding to 1.5 nmole) for measuring the first step of *trans*-peptidation of tmRNA (in that case the bulk of tRNAs was replaced by pure tRNA^Phe^, 313 nM) (iii) ^14^C glutamic acid (0.9 kBq corresponding to 30.75 nmole) for measuring the rate of translation of the internal ORF of tmRNA (iv) ^3^H alanine (92.5 MBq corresponding to 29.25 nmole) for measuring the global rate of *trans*-translation, including the first step of *trans*-peptidation of tmRNA as well as the four alanines encoded by the internal ORF of tmRNA. In each case the corresponding cold amino acid was removed from the reaction mixture. At the end of the respective reactions, the rates of incorporation of the radiolabeled aminoacid were measured by filter binding assays.

In parallel to *trans*-translation, the corresponding rate of translation was measured for each assay by using ^14^C Phenylalanine instead of radiolabeled alanine or glutamic acid. The amount of phenylalanine incorporated was then taken into account to normalize the data and eliminate the influence of S1 on polyU RNA translation. Normalization factors were calculated by dividing the level of translation for each assay by the level of translation for the minus S1 assay. The value of each of the labeled amino acids (Ala, Glu) incorporated at each concentration of protein S1 was divided by its own normalization factor.

Filter binding assays
---------------------

Reactions were terminated by the addition of 1 ml 5% ice-cold TCA, heated for 20 min at 90°C and incubated for 30 min on ice ([@B30]). Incorporated radioactive aminoacids were measured by filtering under vacuum suction on nitrocellulose filters (Schleicher and Schuell), followed by rapid washing with 3 × 2 ml 5% ice-cold TCA and 1 × 1 ml 96% ethanol. Membranes were dried and the holding radioactivity measured by scintillation counting (WALLAC 1409). Background values for each point were measured by using the corresponding samples without any polyU RNAs.

S1 detection by western blotting
--------------------------------

In order to detect remaining S1 protein from ribosomes, 0.3 pmol 70S purified samples were electrophoresed on 10% SDS PAGE gels and transferred to PVDF membranes (Amersham). Western blot analysis was performed using specific anti-S1 antibodies as previously described ([@B31]).

Bacterial strains and measurement of **β**-galactosidase activity
-----------------------------------------------------------------

The PhB2677 strain used in this work contains a chromosomal *ssrAH7* allele encoding the peptide tag ANDENYHHHHHHH ([@B22]). To make a strain from which the essential ribosomal protein S1 can be depleted, we introduced the chromosomal *rpsA::kan* deleted allele into PhB2677 along with the pJFR32 (p*lac rpsA*) plasmid that contains an IPTG inducible wild-type *rpsA* gene ([@B24]). First, strain PhB2677 has been transformed with plasmid pJFR32 and resulting ampicilin resistant strain (Amp^R^) was transduced with a P1 lysate from strain JFR175 \[*rpsA::kanR*, pJFR32 ([@B24])\]. Kanamycin resistant (kan^R^) transductants were selected in the presence of IPTG (1 mM). The resulting *ssrAH7*, *rpsA::kan*, pJFR32 strain (hereafter *ssrAH7 rpsA::kan*) was shown to be dependent of the presence of IPTG for growth and presence of the *rpsA::kan* deleted allele was checked by PCR analysis. To deplete S1, the IPTG inducer was removed from an exponential growing culture (OD~600~ = 0.23) by filtration and cells were rapidly resuspended in an IPTG-free medium. Growth was continued for 4 h and cells harvested (OD~600~ = 0.61). For control, the same strain was continuously grown in the presence of IPTG (1 mM) but a filtration step has been equivalently done and growth continued before harvesting cells. Depletion of S1 has been checked by western blot analyses.

To make strains that expressed increased level of S1, we either grown strain PhB2677 containing the pJFR32 plasmid (hereafter *ssrAH7 rpsA*) in the presence of IPTG (1 mM) or transformed the PhB2677 strain containing the chromosomal *rpsA-lacZ* fusion (see below) with the pS1 plasmid, a derivative of pACYC184 (pAC) that expresses S1 under the control of its own promoter ([@B26]). Increased level of S1 was either checked by Western blotting, or we used β-galactosidase activity measurements to assess the presence of excess free S1 protein: due to autoregulation, higher concentration of free S1 leads to lower activity of the TIR of the chromosomal *rpsA-lacZ* fusion ([@B25]). The resulting chloramphenicol resistant strain (hereafter *ssrAH7 rpsA*, *rpsA-lacZ* pS1) was used for β-galactosidase activity measurements. As control, we used the PhB2677 *rpsA-lacZ* strain transformed by pAC (hereafter *ssrAH7 rpsA*, *rpsA-lacZ* pAC) that expressed endogenous level of ribosomal protein S1. β-Galactosidase activity was assayed as described previously ([@B25]). Each measurement was done at least in triplicate. Strains were grown at 37°C in LB medium supplemented with chloramphenicol (20 μg/ml) and IPTG (500 μM) and collected at OD~600~ of 0.8.

The chromosomal *rpsA-lacZ* fusion has been introduced in the PhB2677 strain by P1 mediated transduction in two steps. First, the *Zah281*::*Tn10* transposon was introduced near the *rpsA-lacZ* fusion of strain HfrG6 rpsA(-91)::lacZ ([@B25]) by selecting for tetracycline resistance (Tet^r^). The *rpsA-lacZ* fusion was then P1 transduced into PhB2677 strain by selecting again for Tet^r^. At each step, strains were confirmed by PCR analyses. Strain *ssrAH7 rpsA*, *rpsA-lacZ* was then transformed with the indicated plasmids.

*In vivo* tagging activity
--------------------------

The *E.coli* strains expressing the ribosomal protein S1 at different levels were grown at 37°C in LB medium. The cells were harvested at OD~600~ 0.4--0.8 and washed once in 10 mM Tris-HCl, 100 mM Na-phosphate, pH 7.4 before freezing. After lysis, equal amounts of total proteins from each bacterial strain were applied to a Ni^2+^-NTA chromatography column under denaturing conditions. His-tagged *trans*-translated proteins were eluted by a linear gradient of imidazole and recovered in 1 ml fractions (Supplementary Data) ([@B22]). A small aliquot of each fraction was electrophoresed in SDS-PAGE gels and submitted to western blot using anti-His antibodies (Ref 34660, Qiagen) in order to detect the presence of tagged proteins. The positive fractions were then pooled and 900 μl applied to a 5 ml HiTrap desalting column (Amersham) in order to discard the imidazole that could interfere with the measurement of protein concentration using absorbance at 280 nm. The following buffer was used to elute the tagged proteins: 100 mM NaH~2~PO~4~, 10 mM Tris-HCl (pH 7). The amounts of *trans*-translated proteins were then measured by peak integration of the desalting column absorbance curve at 280 nm, after subtracting the control curve (Supplementary Data).

SUPPLEMENTARY DATA
==================

Supplementary Data are available at NAR Online.
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